Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of levalbuterol as compared to racemic
albuterol based on the frequencies of adverse events reporting during a 12-month period of
chronic dosing of adolescent and adult subjects with asthma.